The impact of kidney dysfunction on the usefulness of NT-proBNP concentration in the assessment of cardiac function in patients with AL amyloidosis was analyzed in the study by Palladini et al., where the authors have unequivocally stated that, so far, this problem was somewhat overlooked and downplayed. Here, NPPB is linked to AL amyloidosis.